Short answer
Zoetis (ZTS) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $2.5B (up 0.3% year over year) with net income of $691M.
Q2 2026 key financials · XBRL
- Revenue
- $2.5B
- +0.3% YoY · +9.1% QoQ
- Net income
- $691M
- −3.8% YoY · +15.0% QoQ
- EPS (diluted)
- $1.66
- +3.1% YoY · +16.9% QoQ
Source: XBRL data from the Zoetis (ZTS) Q2 2026 10-Q on SEC EDGAR. USD.
Zoetis Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $2,468M vs $2,474M, down $6M and 0% total growth
- Net income $691M vs $726M, down $35M; adjusted net income $781M vs $791M
- International segment impacted by delayed December 2025 orders and fiscal-year alignment
- Foreign exchange favorably impacted year-over-year revenue growth by approximately 2%
- Tariffs, disease outbreaks, supply disruptions, geopolitical tensions and macroeconomic weakness as near-term headwinds
Risk Factors
- No Risk Factors section provided; filing text begins with Item 2
- Share-repurchase execution risk: $1.3 billion remaining under authorization as of June 30, 2026
- Convertible-note funding exposure: $1,783 million net proceeds used for share repurchases
- Market-price risk: quarterly repurchases averaged $88.59 per share
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Zoetis quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.